NCT01465191View on ClinicalTrials.gov

Effect of Mu-opioid Receptor Genetics on 3 Doses of Spinal Morphine for Postoperative Analgesia After Cesarean Section

PHASE4CompletedINTERVENTIONAL
Enrollment

169

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

May 31, 2014

Study Completion Date

May 31, 2014

Conditions
Postoperative Pain
Interventions
DRUG

Morphine

Morphine will be given via spinal injection at doses of 50, 100, 150 micrograms as part of a spinal anesthetic for cesarean section

Trial Locations (2)

10032

Columbia University Medical Center, New York

20037

George Washington University Medical Center, Washington D.C.

All Listed Sponsors
lead

Columbia University

OTHER

NCT01465191 - Effect of Mu-opioid Receptor Genetics on 3 Doses of Spinal Morphine for Postoperative Analgesia After Cesarean Section | Biotech Hunter | Biotech Hunter